Pure Eye Muscle Involvement in Endocrine Orbitopathy
暂无分享,去创建一个
[1] A. Frauman,et al. TSH receptor protein is selectively expressed in normal human extraocular muscle , 2005, Muscle & nerve.
[2] P. Chinnery,et al. Extraocular muscles have fundamentally distinct properties that make them selectively vulnerable to certain disorders , 2005, Neuromuscular Disorders.
[3] Robert A Goldberg,et al. Extraocular muscle enlargement with tendon involvement in thyroid-associated orbitopathy. , 2004, American journal of ophthalmology.
[4] L. Seah,et al. Thyroid autoantibody profiles in ophthalmic dominant and thyroid dominant Graves’ disease differ and suggest ophthalmopathy is a multiantigenic disease , 2004, Clinical endocrinology.
[5] J. Wall,et al. Eye muscle antibodies in Graves’ ophthalmopathy: Pathogenic or secondary epiphenomenon? , 2004, Journal of endocrinological investigation.
[6] M. Nardi,et al. Multi-center study on the characteristics and treatment strategies of patients with Graves' orbitopathy: the first European Group on Graves' Orbitopathy experience. , 2003, European journal of endocrinology.
[7] A. Lindner,et al. Successful treatment of orbital myositis with intravenous immunoglobulins , 1998, Muscle & nerve.
[8] G. Kahaly,et al. Endokrine Orbitopathie 1998 , 1998, Medizinische Klinik.
[9] C. Spitzweg,et al. Pathogenese der immunogenen Hyperthyreose und endokrinen Orbitopathie , 1998, Der Internist.
[10] S. Nagataki,et al. Untreated Graves' disease patients without clinical ophthalmopathy demonstrate a high frequency of extraocular muscle (EOM) enlargement by magnetic resonance. , 1995, The Journal of clinical endocrinology and metabolism.
[11] A. Osborn,et al. Computed tomographic features of nonthyroid extraocular muscle enlargement. , 1989, Ophthalmology.
[12] A. Weetman,et al. Graves' disease , 1988 .
[13] C. Hess,et al. Okuläre Myositis , 1997, Der Nervenarzt.